Hercules Capital, Inc. 6.25% Notes due 2033 (HCXY)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 30, 2025 | $0.39 | 2025-10-15 | 2025-10-15 |
| July 30, 2025 | $0.39 | 2025-07-15 | 2025-07-15 |
| April 30, 2025 | $0.39 | 2025-04-15 | 2025-04-15 |
| January 30, 2025 | $0.39 | 2025-01-15 | 2025-01-15 |
| October 30, 2024 | $0.39 | 2024-10-15 | 2024-10-15 |
Dividends Summary
- Hercules Capital, Inc. 6.25% Notes due 2033 has issued 25 dividend payments over the past 6 years
- The most recent dividend was paid 5 days ago, on October 30, 2025
- The highest dividend payed out to investors during this period was $0.39 per share
- The average dividend paid during this period was $0.39 per share.
Company News
Sound Income Strategies sold 177,473 shares of Hercules Capital for approximately $3.40 million in Q3 2025, reducing its stake while maintaining over 2.7 million shares. Hercules Capital has underperformed the S&P 500 over the past year.
Ashland Inc. announced Karl Bostaph's retirement as senior vice president of operations, with Wayne Muil taking over the role effective immediately. Muil brings over 25 years of global operations experience and will oversee Ashland's production facilities worldwide.
Hercules Capital Inc.'s Q2 2024 net investment income matched estimates, but declined year-over-year due to higher operating expenses. The company's total investment income and portfolio value remained strong, but expenses rose due to increased interest and compensation costs.
Eloxx Pharmaceuticals, a biopharmaceutical company, has secured an additional $3.175 million in funding through a loan agreement amendment with Hercules Capital and other lenders. The funding will be used for the company's operations and development of its ELX-02 compound.